Two Sigma Advisers’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History

Two Sigma Advisers’s Portfolio BLCM Stock Details BLCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-4,070	Closed	-$53K	–	2604
2019 Q4	$53K	Sell	4,070 -1,530	-27%	-$14.1K	﹤0.01%	2291
2019 Q3	$59K	Buy	5,600 +550	+11%	+$7.19K	﹤0.01%	2147
2019 Q2	$86K	Buy	5,050 +400	+9%	+$10.8K	﹤0.01%	2225
2019 Q1	$157K	Buy	4,650 +2,150	+86%	+$71.9K	﹤0.01%	2149
2018 Q4	$73K	Buy	+2,500	New	+$111K	﹤0.01%	2248
2016 Q2	–	Sell	-2,760	Closed	-$258K	–	2233
2016 Q1	$258K	Buy	+2,760	New	+$300K	﹤0.01%	1739

Other funds holding BLCM

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Two Sigma Advisers's BLCM Position: Q1 2020 in Review

Two Sigma Advisers sold out of Bellicum Pharmaceuticals, Inc. (BLCM) in Q1 2020, closing a stake of 4,070 shares — an estimated $53K sold.

Two Sigma Advisers first reported a position in BLCM in Q1 2016 and held it in 6 quarters. The position peaked at $258K in Q1 2016. 29 funds tracked by Wall St. Rank hold BLCM as of Q1 2020.

Two Sigma Advisers reported no remaining Bellicum Pharmaceuticals, Inc. position as of Q1 2020 after selling out during the quarter.
Two Sigma Advisers sold 4,070 Bellicum Pharmaceuticals, Inc. shares in Q1 2020, an estimated $53K.
Two Sigma Advisers first reported a position in Bellicum Pharmaceuticals, Inc. in Q1 2016 and held it in 6 quarters.
Two Sigma Advisers's Bellicum Pharmaceuticals, Inc. position peaked at $258K in Q1 2016.
29 funds tracked by Wall St. Rank held Bellicum Pharmaceuticals, Inc. as of Q1 2020.

Based on Two Sigma Advisers's 13F filing for Q1 2020, filed 15 May 2020.